Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area

South African Medical Journal

Volumn 100, Issue 9, 2010, Pages 598-601

  Sathekge, Mike Machaba ^a   Maes, Alex ^b   Pottel, Hans ^c   Stoltz, Anton ^a   van de Wiele, Christophe ^d  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b AZ GROENINGE   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; FEMALE; HAMARTOMA; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG METASTASIS; LUNG NODULE; LUNG SQUAMOUS CELL CARCINOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE DIAGNOSIS; RHEUMATOID NODULE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TUBERCULOMA; TUBERCULOSIS; TUMOR VOLUME;

EID: 77957668923     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4082     Document Type: Article

References (15)

1. Cronin P. Thoracic CT. Appl Radiol 2003; 32: 14-27.
2. Winer-Muram H. The solitary pulmonary nodule. Radiology 2006; 239: 34-49.
3. Lillington GA. Disease-a-Month. 37th ed. St Louis, MO: Mosby-Yearbook, 1991: 271-318.
4. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285: 914-924.
5. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109: 982-988.
6. Kapucu LO, Meltzer CC, Townsend DW, Keenan R, Luketich J. Fluorine-18- fluorodeoxyglucose uptake in pneumonia. J Nucl Med 1998; 39: 1267-1269.
7. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual-time-point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43: 871-875.
8. Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med 2001; 28: 696-703.
9. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412-1417.
10. Chen C, Lee B, Yao W, et al. Dual-phase 18F-FDG PET in the diagnosis of pulmonary noduels with an initial standard uptake value less than 2.5. AJR Am J Roentgenol 2008; 191: 475-479.
11. Duhaylongsod F, Lowe V, Patz E, Vaughn A, Coleman R, Wolfe W. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110: 130-139.
12. Lowe V, Duhaylongsod F, Patz E, et al. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997; 202: 435-439.
13. Xiu J, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 2007; 32: 101-105.
14. Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2000; 42: 1551-1555.
15. Barbosa Pereira P, Empadinhas N, et al. Mycobacterium tuberculosis glucosyl-3-phosphoglycerate synthase: structure of a key enzyme in methylglucose lipopolysaccharide biosynthesis. PloS ONE 2008; 3: 1-12.